MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy

NCT01851252 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Liver Disease
Cirrhosis
Esophageal Varices
Portal Hypertension
Bleeding

Interventions

DEVICE: Methacetin (with Breath testing device)

Sponsor

Meridian Bioscience, Inc.